FDA Import Refusal AEK-1574899-7/11/1 — Hetero Labs Ltd
The FDA refused shipment AEK-1574899-7/11/1 from Hetero Labs Ltd (India) on August 12, 2022. The refused product falls under Drugs and Biologics — HYDROXYCHLOROQUINE SULFATE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- August 12, 2022
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62LDY29 HYDROXYCHLOROQUINE SULFATE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL)
- Charges
- 75